A PYMNTS Company

US Rep. Neguse Wants House Antitrust Panel To Go After Big Pharma

By  |  November 24, 2020

A top Democrat on the House Judiciary subcommittee on antitrust has his sights set on Big Pharma. He believes it should be the next target after wrapping up a more than year-long investigation into Amazon, Apple, Facebook, and Google.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Rep. Joe Neguse (Democrat – Colorado), vice chairman of the subcommittee, is calling for a hearing to probe federal enforcers’ approach to evaluating pharmaceutical mergers, reported CNBC.

    He made the request in a letter sent Monday, November 23, to committee Chairman Jerrold Nadler (Democrat – New York) and subcommittee Chairman David Cicilline (Democrat – Rhode Island). From there, Neguse told CNBC, the committee could determine if a full investigation is warranted.

    “I think that this first hearing could be a starting point of sorts in providing both the committee and the American public with a better understanding of the scope of issues,” Neguse said in a phone interview. “And from there, depending on what we glean during that hearing regarding the FTC’s merger policy, I think it could very well lead to a broader investigation similar to the investigation that the committee undertook in the digital economy and Big Tech.”